12-Month Outcomes from a Randomized, Sham Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
Kaplan SA, Parekattil SJ, Wu NZ, Mazzarella B, Trotter M, Freedman S, Lawindy S, Bukkapatnam R, Schwartz BF, Jones B, Sethi P, Jalkut M, Liu JS, Elterman D, Gheiler E, Gonzalez RR, Kaminetsky J, Motola JA, Te A, Chapple C, Lerner L, Lynch T.
Kaplan SA, et al. Among authors: liu js.
J Urol. 2025 Dec 15:101097JU0000000000004896. doi: 10.1097/JU.0000000000004896. Online ahead of print.
J Urol. 2025.
PMID: 41396103